MOB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Moberg Pharma AB (publ)

Watchlist Manager

Watchlist

Price: 9.47 SEK 0.74% Market Closed

Market Cap: kr461.3m

	Moberg Pharma AB (publ) STO:MOB	SE
	Life Healthcare Group Holdings Ltd OTC:LTGHF	ZA
M	Manhattan Associates Inc XMUN:MHT	US
	Natwest Group PLC F:RYSD	UK

Profitability Summary

Moberg Pharma AB (publ)'s profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

57%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

100% > 57%

Negative Operating Margin

-207%

Negative 3Y Average Operating Margin

-2 570%

Operating Margin is Increasing

-10 546% > -207%

Negative Net Margin

-201%

Negative 3Y Average Net Margin

-2 239%

Net Margin is Increasing

-7 848% > -201%

Negative Free Cash Flow Margin

-129%

Negative 3Y Average Free Cash Flow Margin

-1 766%

Free Cash Flow Margin is Increasing

-10 437% > -129%

Negative ROE

-4%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-17%

Declining ROIC

-4% > -7%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.